Colgate Palmolive Co (CL) company profile
Close on Nov 13, 2026Market cap $79.23BP/E 39.1Yield 2.09%
About Colgate Palmolive
Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844
Colgate-Palmolive Company produces and sells oral, personal, home care, and pet nutrition products worldwide. Its oral care offerings feature toothpastes, toothbrushes, mouthwashes, and specialized dental pharmaceuticals. Within personal care, the enterprise manufactures liquid and bar soaps, shower gels, deodorants, antiperspirants, skin health items, and hair care formulations. Home care operations include dishwashing liquids, fabric conditioners, and household surface cleaners. Additionally, its pet nutrition business manufactures everyday and therapeutic foods for canines and felines, including fresh dietary selections. The company supplies wholesale distributors, brick-and-mortar retailers, pet specialty outlets, veterinarians, and eCommerce platforms, alongside direct-to-consumer sales.
The enterprise distributes products across more than 200 countries and territories, marketing its pet nutrition items in over 80 jurisdictions. Its workforce comprises roughly 33,600 employees stationed across more than 100 nations, with major regional personnel presence in the Asia Pacific, Latin America, North America, Europe, and Africa/Eurasia. The company maintains an operating presence that includes manufacturing facilities internationally. The provided text identifies the company's incorporation under Delaware state laws, though it does not state a headquarters city or address.
Summary of the business section of Colgate Palmolive's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Colgate Palmolive Co
- Founded
- 1806
- Headquarters
- New York, NY
- Address
- 300 Park Ave 10022
- Phone
- (212) 310-2000
- Website
- colgatepalmolive.com
- Employees
- 33,600, Dec 31, 2025
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, New York, New York
Stock & identifiers
- Ticker
- CL
- Exchange
- NYSE
- IPO date
- May 2, 1973
- Shares outstanding
- 795M, Sep 30, 2026
- Public float
- $73.40B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, May 16, 2013; 2-for-1, Jul 1, 1999; 2-for-1, May 16, 1997; 2-for-1, May 16, 1991; 3-for-1, May 30, 1973
- SEC CIK
- 21665
- CUSIP
- 194162103
- ISIN
- US1941621039
- FIGI
- BBG000BFQYY3
- Share class FIGI
- BBG001S5PVM5
- LEI
- YMEGZFW4SBUSS5BQXF88
- EIN
- 13-1815595
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Noel R. Wallace | Chairman, President & CEO, Director | 467,208 |
| Gregory Malcolm | EVP and Controller | 18,761 |
| Panagiotis Tsourapas | COO, CD, EMEA, APac, Skin | 80,993 |
| John Hazlin | Chief Growth Officer | 32,565 |
| Betsy Fishbone | CLO and Secretary | 24,436 |
| Sally Massey | Chief People Officer | 23,596 |
| Shane Grant | COO, Americas | 79,503 |
| Stanley J. Sutula Iii | Chief Financial Officer | 79,360 |
| Jennifer Daniels | CLO and Secretary | 91,681 |
| Prabha Parameswaran | Vice Chair | 63,783 |
| Lorrie M. Norrington | Director | 43,383 |
| Brian Newman | Director | 8,094 |
| John P. Bilbrey | Director | 45,444 |
| John T. Cahill | Director | 64,730 |
| Lisa Edwards | Director | 18,182 |
| Martina Hundmejean | Director | 16,206 |
| C. Martin Harris | Director | 24,517 |
| Kimberly A. Nelson | Director | 14,223 |
| Christopher S. Boerner | Director | 1,383 |
| Steven A. Cahillane | Director | 6,754 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $16.48M | $12.34M | $6.36M | $104 | $112 |
| FY2024 | $18.23M | $31.68M | $4.88M | $117 | $113 |
| FY2023 | $17.12M | $19.46M | $4.71M | $100 | $108 |
| FY2022 | $14.46M | $11.05M | $4.06M | $97 | $113 |
| FY2021 | $15.46M | $18.01M | $4.09M | $102 | $114 |
| FY2020 | $14.36M | $22.77M | $4.02M | $127 | $111 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Noel Wallace Chairman, President and Chief Executive Officer | $1.50M | – | $8.01M | $3.57M | $2.46M | $947.08K | $16.48M | -10% |
| Stanley J. Sutula III Chief Financial Officer | $1.10M | – | $2.07M | $1.05M | $1.19M | $252.41K | $5.66M | -5% |
| Jennifer M. Daniels Chief Legal Officer and Secretary | $952.71K | – | $1.30M | $579.01K | $718.39K | $222.36K | $3.77M | -13% |
| Shane Grant Chief Operating Officer, Americas (7) | $592.31K | $500.00K | $8.41M | $450.01K | $1.18M | $788.35K | $11.92M | – |
| Panagiotis Tsourapas Chief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev. | $1.00M | – | $1.31M | $600.00K | $871.76K | $293.64K | $4.08M | -9% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 33,600 employees based in over 100 countries.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?